Kobayashi Pharmaceutical received JPY 500 billion buyout proposal for Kobayashi Pharma stock
Published on 10/25/2026 at 03:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBuyout proposal and reporting date
- A September 25, 2026 proposal could exceed JPY 500 billion.
- Second-quarter revenue reached JPY 37.084 billion in fiscal 2026.
- The next earnings date is November 10, 2026.
Kobayashi Pharmaceutical (JP3301100008) received a preliminary buyout proposal that could exceed JPY 500 billion on September 25, 2026, according to Ground News. CVC Capital Partners and Nippon Sangyo Suishin Kiko were cited as potential bidders, placing the companys recovery after the red-yeast rice issue at the center of the investment case.
Three dates changed the picture
The chronology is clear. On May 8, 2026, Kobayashi Pharmas investor-relations page listed fiscal 2026 first-quarter results. On August 6, 2026, reported second-quarter revenue reached JPY 37.084 billion and net income was JPY 100.0 million, according to Investing.com. On September 25, 2026, the buyout proposal became the latest major corporate event.
What does the proposal mean?
The JPY 500 billion scale exceeds 13.48 times the reported second-quarter revenue of JPY 37.084 billion. That comparison does not establish a tender price, because the proposal was preliminary and nonbinding, but it shows why the discussion is about control and restructuring rather than a routine capital return.
The market picture remains demanding. Kobayashi Pharmas last JPX price was JPY 7,128 on October 23, 2026 at 3:30 p.m. JST. The 52-week range was JPY 5,030.00 to JPY 7,388.00, leaving the stock 3.52 percent below its high. Market capitalization stood at JPY 529.9 billion on the same date.
Next reporting date is November 10
The next earnings date is November 10, 2026, as listed by TradingView. The fiscal 2026 year ends on December 31, 2026, according to the companys investor-relations calendar. For investors, the key question is whether the next report adds operating detail to a proposal whose headline value is known but whose final terms are not.
Tokyo valuation stays central
Kobayashi Pharma stock was last at JPY 7,128 on JPX on October 23, 2026 at 3:30 p.m. JST. The next report will provide the clearest scheduled test of earnings after the buyout proposal.
The further course of trading is shown by the continuously updated real-time quote of Kobayashi Pharma stock.
Kobayashi Pharma stock facts
- Company: Kobayashi Pharmaceutical Co., Ltd.
- ISIN: JP3301100008
- Ticker: 4967
- Primary exchange: JPX
- Market capitalization: JPY 529.9 billion (as of October 23, 2026)
- 52-week range: JPY 5,030.00-7,388.00 (as of October 23, 2026)
- Next earnings date: November 10, 2026
Market context: Market report Nikkei 225.
